16 results on '"Bozhok A"'
Search Results
2. The influence of environmental factors on structural durability of reinforced bridges and cement concrete road pavements
3. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
4. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
5. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
6. NA cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident : Cytohistopathologic correlation and accuracy of fine-needle aspiration biopsy in nodules detected during the first screening in Ukraine (1998-2000)
7. Expression of epidermal proteins resembling cytokeratin No. 2 in human prostatic epithelial cell cultures
8. Conversion of methane/carbon dioxide mixtures on vermiculite
9. 248. Breast recurrence after conservative surgery in patient with minimal (pT1a-bN0M0) breast cancer (significance of molecular subtype).
10. 0177 Primary endocrine therapy versus chemotherapy in postmenopausal patients with ER-positive breast cancer: 5-year results.
11. 2042 POSTER Trasuzumab in multimodality treatment of inflammatory breast carcinoma.
12. P131 The neoadjuvant endocrinetherapy vs chemotherapy in postmenopausal woment with ER-positive breast cancer.
13. 277 POSTER Breast-conserving surgery (BCS) following neoadjuvant endocrine therapy: exemestane (E) vs tamoxifene (T) in postmenopausal (PM) women with ER-positive breast cancer (T2N1, T3NO-1, T4NOMO).
14. Primary endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients.
15. P85 Direct comparison of primary (neoadjuvant) endocrine therapy vs primary chemotherapy in postmenopausal women with ER-positive breast cancer.
16. P85 Direct comparison of primary (neoadjuvant) endocrine therapy vs primary chemotherapy in postmenopausal women with ER-positive breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.